Answers are grounded in this paper and cite their sources.
Dental pulp regeneration aims to restore the structure and function of the pulp-dentin complex beyond infection control. Root canal therapy removes diseased pulp, whereas pulpotomy preserves the remaining vital pulp; neither is intended to regenerate the entire pulp after its loss. This review examines which odontogenic stem-cell subpopulations have evidence of regenerative activity, how biomaterials can meet specific regenerative demands, and which clinical scenarios support cell transplantation or cell homing. Dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHED), and stem cells from the apical papilla (SCAP) are compared, with distinctions between transcriptomic cell states and functionally validated subsets. Biomaterials are organised by cell delivery, structural support, infection control, and controlled signalling for dentin, vascular, and neural tissue formation. Nanoscale features are considered modifications of these systems. Apical-bleeding regenerative endodontic procedures use endogenous cell homing, principally in immature permanent teeth with pulp necrosis. Cell transplantation has early clinical evidence in selected immature injured teeth and pulpectomised mature teeth, but remains investigational. Material selection must account for root maturity, infection control, vascular access, and the requirements of the chosen cellular strategy. This review links these considerations to the strength and limitations of the available evidence for functional pulp regeneration.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: